Clinical Trials Browser

Loratadine × Clear all

NCT07101445 2026-02-10

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Phase 4 Recruiting

Multiple Myeloma

NCT07300735 2025-12-29

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

Phase NA Recruiting

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

NCT06265077 2024-12-13

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Phase 1/2 Completed

Breast Neoplasms

NCT04211259 2023-08-07

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

Phase EARLY_PHASE1 Unknown

Multiple Myeloma

NCT05190627 2022-01-27

LORALAM

Phase 2 Unknown

Lymphangioleiomyomatosis

NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

Phase EARLY_PHASE1 Terminated

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT02305979 2018-07-03

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT01712009 2018-01-30

NOLAN

Phase 2 Completed

600 enrolled 15 charts

Breast Neoplasms

NCT02007434 2015-07-28

Patient Experience Study of Deoxycholic Acid Injection

Phase 3 Completed

84 enrolled 24 charts

Lymphoma, Follicular